SCHEMBL4416080

SCHEMBL4416080

CS(=O)(=O)c1cnc(-c2ccc(Cl)nc2)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 2/20 0.41
CYP2A6 P11509 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
MAPT P10636 1/20 0.37
PIP5K1C O60331 1/20 0.36
PIK3CB P42338 1/20 0.36
PI4KA P42356 1/20 0.36
PIK3CG P48736 1/20 0.36
PI4KB Q9UBF8 1/20 0.36
NOTUM Q6P988 1/20 0.36
ALDH1A1 P00352 1/20 0.35
PTGS2 P35354 3/20 0.35
MAPK1 P28482 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNA4 P43681 1/20 0.35
KCNH2 Q12809 1/20 0.35
FAAH O00519 1/20 0.34
PTGS1 P23219 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26106996 0.84 PIK3CD (0.48) PIK3CDCYP2A6SMN1; SMN2MAPTPIP5K1C
SCHEMBL422105 0.78 SIRT6 (0.38) PIK3CDSMN1; SMN2MAPTPIP5K1CPIK3CB
SCHEMBL19260832 0.73 CA12 (0.36) PIK3CDSMN1; SMN2PIP5K1CPIK3CBPI4KA
SCHEMBL31002433 0.72 ALOX5AP (0.38) PTGS2
SCHEMBL26107943 0.72 PI4KB (0.55) PIK3CDPIP5K1CPIK3CBPI4KAPIK3CG
SCHEMBL21266740 0.72 PIK3CD (0.66) PIK3CDCYP2A6PIK3CBPIK3CGNOTUM
SCHEMBL6050864 0.69 PTGS2 (0.60) PTGS2PTGS1ABCC4ABCB11PDE4D
SCHEMBL29977958 0.69 SMN1; SMN2 (0.59) SMN1; SMN2MAPTALDH1A1MAPK1MEN1
SCHEMBL1256644 0.69 SMN1; SMN2 (0.59) SMN1; SMN2MAPTALDH1A1MAPK1MEN1
SCHEMBL1662273 0.69 PIK3CD (0.73) PIK3CDCYP2A6NOTUMALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2133340-B1 Novel benzazepine derivatives GLAXO GROUP LTD (GB) 2013-01-16 EP disclosed
EP-2133340-A1 Novel benzazepine derivatives Glaxo Group Limited (GB) 2009-12-16 EP disclosed
CN-1326838-C Benzo[d]azepine derivatives for the treatment of neurological disorders GLAXO GROUP LTD (GB) 2007-07-18 CN disclosed
CN-1726042-A Benzo[d]azepine derivatives for the treatment of neurological disorders GLAXO GROUP LTD (GB) 2006-01-25 CN disclosed